Marrone Bio Innovations (MBII) Financials

$196.6 M

Mkt cap, 25-May-2018

$4.3 M

Revenue Q1, 2018
Net income (Q1, 2018)-2.9 M
EBIT (Q1, 2018)-5.5 M
Cash, 31-Mar-201814.8 M
EV183.7 M

Revenue/Financials

Income Statement

Annual

USDFY, 2013Y, 2014FY, 2015FY, 2016

Revenue

14.5 m1.1 m9.8 m14 m

Revenue growth, %

(92%)793%43%

General and administrative expense

18.5 m

Operating expense total

18.5 m

EBIT

(29 m)(15.5 m)(39.5 m)(23.7 m)

EBIT margin, %

(200%)(1416%)(403%)(168%)

Interest expense

6 m669 k2.8 b2.9 m

Interest income

49 k17 k51 m37 m

Pre tax profit

(28.5 m)(16.2 m)(43.7 m)(31.1 m)

Income tax expense

Net Income

(28.5 m)(16.2 m)(43.7 m)(31.1 m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.3 m2.8 m3.6 m2.1 m3.4 m2.5 m2.7 m5 m3.6 m4.2 b6.5 b4.2 m4.3 m

R&D expense

4.5 m

General and administrative expense

4.5 m6.3 m6 m7.9 m7.4 m5.3 m5.5 m4.5 m3.8 m5.3 b5.1 b5.2 m5 m

Operating expense total

8.9 m10.6 m10.3 m11.3 m10.7 m8.8 m7.9 m6.8 m6.4 m7.8 b7.9 b8.3 m7.6 m

Depreciation and amortization

1.5 m

EBIT

(8.7 m)(9.5 m)(9.5 m)(11.3 m)(10.4 m)(8.6 m)(7.5 m)(4.9 m)(5.3 m)(5.9 b)(5.4 b)(6.6 m)(5.5 m)

EBIT margin, %

(645%)(340%)(261%)(547%)(309%)(348%)(279%)(97%)(145%)(142%)(84%)(156%)(127%)

Interest expense

1.1 m773 k825 k669 k659 k687 k1 m759 k755 k636 m869 m804 k1.1 m

Interest income

24 k10 k11 k9 k6 k14 k15 k10 k8 k1 m

Pre tax profit

(6.1 m)(10.2 m)(10.4 m)(11.9 m)(11 m)(9.8 m)(9.3 m)(6.8 m)(7.2 m)(7.6 b)(7.4 b)(8.5 m)

Income tax expense

Net Income

(6.1 m)(10.2 m)(10.4 m)(11.9 m)(11 m)(9.8 m)(9.3 m)(6.8 m)(7.2 m)(7.6 b)(7.4 b)(8.5 m)(2.9 m)

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

24.5 m35.3 m19.8 m9.6 m

Accounts Receivable

6.2 m1.8 m2.3 m3.6 m

Inventories

1.7 m1.3 m1.3 m8.5 m

Current Assets

58.7 m54.7 m36 m26.9 m

PP&E

9.4 m20.2 m18.4 m17.3 m

Total Assets

68.9 m77.2 m71.8 m46 m

Accounts Payable

4.5 m5.8 m2 m1.4 m

Short-term debt

Current Liabilities

11.7 m31.2 m12.9 m15.2 m

Long-term debt

Total Liabilities

76.2 m

Preferred Stock

Additional Paid-in Capital

147.2 m193.1 m201.6 m204.5 m

Retained Earnings

(105.4 m)(159.8 m)(203.6 m)(234.6 m)

Total Equity

41.8 m33.2 m(2 m)(30.2 m)

Financial Leverage

1.6 x2.3 x-35.5 x-1.5 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

40.8 m21.3 m57.6 m22.4 m12.2 m27.8 m9.8 m21.2 m16 m1.8 m10.2 m3.7 m14.8 m

Accounts Receivable

2.1 m7.2 m4.1 m2.2 m3 m1.4 m4.7 m4.5 m2.1 m8.1 m5.8 m1.9 m4.4 m

Inventories

10.8 m12.8 m12.5 m11.8 m10.6 m9.8 m8.6 m8 m8.4 m8.1 m8.4 m9.3 m10 m

Current Assets

68.6 m47 m80.1 m41.1 m30.2 m43.4 m28.1 m37.8 m30.6 m24.4 m29.6 m19.5 m30.4 m

PP&E

5.7 m15.8 m18.5 m20.1 m20.1 m19.3 m19.1 m18.5 m17.9 m16.9 m16.5 m16.2 m15.7 m

Total Assets

75.4 m63.5 m101 m63.4 m52.5 m80.1 m64 m58.2 m50.2 m43 m47.8 m37.4 m48 m

Accounts Payable

5.1 m8.6 m5.2 m4.1 m3.2 m1 m2.6 m2.2 m2.2 m3 m3.2 m2.7 m2.6 m

Short-term debt

1.7 m1.9 m

Current Liabilities

10.2 m14.5 m11.4 m28.6 m27.7 m11.5 m13.4 m13.8 m12.6 m18.6 m21.7 m28.1 m11.6 m

Total Debt

1.7 m1.9 m

Total Liabilities

25 m29.5 m36 m41 m40 m72 m74.7 m74.9 m73.5 m80.2 m83.5 m81.1 m34.3 m

Additional Paid-in Capital

145.9 m149.6 m191.1 m194.2 m195.3 m200.6 m202.2 m202.9 m203.6 m205.1 m214 m214.5 m279.9 m

Retained Earnings

(95.4 m)(115.7 m)(126.1 m)(171.8 m)(182.7 m)(192.5 m)(212.9 m)(219.6 m)(226.8 m)(242.3 m)(249.7 m)(258.2 m)(266.2 m)

Total Equity

50.4 m34 m65 m22.4 m12.5 m8.1 m(10.7 m)(16.7 m)(23.2 m)(37.2 m)(35.7 m)(43.7 m)13.8 m

Financial Leverage

1.5 x1.9 x1.6 x2.8 x4.2 x9.9 x-6 x-3.5 x-2.2 x-1.2 x-1.3 x-0.9 x3.5 x

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.5 m)(16.2 m)(43.7 b)(31.1 m)

Depreciation and Amortization

976 k2.2 m

Accounts Receivable

(3.4 m)1.8 m(1.2 m)

Inventories

(6.8 m)1.3 m582 k

Accounts Payable

1.7 m5.8 m(588 k)

Cash From Operating Activities

(34 m)(15.5 m)(24.3 m)

Purchases of PP&E

(4 m)(209 k)

Cash From Investing Activities

(17.7 m)(209 k)

Long-term Borrowings

(9.4 m)(260 k)

Cash From Financing Activities

66.1 m14.3 m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(6.1 m)(10.2 m)(10.4 m)(11.9 m)(22.9 m)(32.7 m)(9.3 m)(16.1 m)(23.3 m)(7.6 b)(2.9 m)

Depreciation and Amortization

833 k1.7 m2.6 m594 k1.2 m1.7 m478 k

Accounts Receivable

7.2 m4.1 m(383 k)(1.2 m)398 k(2.3 m)(2.2 m)292 k8.1 m(567 k)

Inventories

869 k2 m2.9 m504 k1.1 m659 k(220 k)

Accounts Payable

8.6 m5.2 m(1.6 m)(2.3 m)(4.4 m)583 k196 k223 k3 m(1.1 m)

Cash From Operating Activities

(11.4 m)(20.4 m)(28.7 m)(9.7 m)(13.5 m)(18.4 m)(9.7 m)

Purchases of PP&E

(1 m)(1.4 m)(1.5 m)(49 k)(93 k)(169 k)(362 k)

Cash From Investing Activities

(1 m)(1.4 m)(1.5 m)(49 k)(93 k)(169 k)(362 k)

Long-term Borrowings

(97 k)(192 k)(371 k)(65 k)(129 k)(195 k)(67 k)

Cash From Financing Activities

(589 k)(1.3 m)22.7 m(253 k)14.7 m24.1 m

Interest Paid

2.1 m

Income Taxes Paid

Ratios

USDY, 2018

EV/EBIT

-33.6 x

EV/CFO

-18.9 x

Financial Leverage

3.5 x
Report incorrect company information